Try our Advanced Search for more refined results
Life Sciences - September, 2011
177 articles
- Law360 Names Most Innovative Corporate Counsel
- Alcon Can't Toss Inventor's Lens Patent Suit
- Glenmark Can't Nix Abbott's $16M Win Over Tarka Patent
- FDA Aims To Speed Reviews Of New, Low-Risk Devices
- Ex-Pfizer Employees Want Class Cert. In ERISA Suit
- Judge Clears $6M DIP Loan To Fund Graceway Ch. 11 Sale
- CVS Caremark Says Rival SXC Lured Away Workers
- DOJ Probes Cephalon Over Narcolepsy Drug Marketing
- NJ Court Shuts Down Suits Over Hormone Therapy Labeling
- AstraZeneca, Handa Settle Seroquel Patent Fight
- Leason Ellis Adds 2 IP Pros To Pharma, Biotech Group
- Merck Pays $1.6M To End Idaho AWP Fight
- Bayer Settles False Ad Suit Over Rival Acne Med
- FDA Warns Eye Doctors Again Over Laser Surgery Ads
- Contact Lens Claims Preempted By FDA Regs: 9th Circ.
- Debevoise Reps Drugmaker Galderma In Graceway Buy
- Sandoz Antitrust Claims Nixed In Bayer's Yasmin IP Suit
- Lawyers To Supreme Court: Hear These Cases
- Case Study: In Re McNeil Consumer Healthcare
- NIDDK Can't Cancel Small Business Contract Offer: Judge
- Investor AB Spins Off Venture Capital Firm
- Merck To Pay $1.5M Penalty In EPA Pollution Case
- Insider Trading Suit Over Sanofi Deal Stays Alive
- Boston Sci Didn't Infringe Cordis Stent IP: Fed. Circ.
- Corporate Political Spending Post-Citizens United
- Asbestos Plaintiffs Pursue Pfizer For $10M In 2nd Circ.
- AstraZeneca GC Joins McDermott's Life Sciences Group
- Precision BioSciences Fires New Round In DNA IP Feud
- Another Beetle-Tainted Similac Suit Sliced Apart
- Blood Clot Risk May Rise With Some Contraceptives: FDA
- US Seeks Leukemia Drug Docs In Cephalon Marketing Probe
- Pfizer Targets Teva's Generic Viagra In Russia
- High Court To Mull If Winners Can Bill For Translation
- Hill-Rom Settles Medicare Fraud Case For $42M
- Cravath Reps AmerisourceBergen In $250M CVS Unit Buy
- Merck V. Garza: Now We're Really Confused
- Pain Med Testing Companies Battle Over False Ad Claims
- FDA Chemist Faces New Charges Before Possible Plea Deal
- Insurer Sues Kornegay Over Hepatitis B Claims Coverage
- Funds' Flonase Antitrust Suit Survives GSK Dismissal Bid
- AstraZeneca Settles Toprol Antitrust Action For $20M
- Boston Scientific Beats Investor Suit Over Bad Defibrillators
- Occlutech CEO Nabs Win In Patent Row With St. Jude Unit
- Guidant Settles FCA Claims For $9.25M
- Ky. Gets Purdue Oxycontin Case Sent To State Court
- RyMed, ICU Get New Trial In IV Valve Patent Fight
- Amgen Asks High Court To Take Up FCA Kickback Case
- Stan Lee's Co. Sued Over Sports Superhero Idea
- Isis Calls Out Santaris Over Drug Development Deals
- Judge Won't Rethink Ruling In Applied, Covidien IP Row
- J&J Scalpel Unit Can't Duck Tyco Patent Suit
- FTC Asks Omnicare For More Info On PharMerica Bid
- Patent Reform Law To Curb Inequitable Conduct Claims
- Sandoz Sues Watson, Amphastar Over Generic Lovenox
- Ex-Armor Co. Execs' $80M Insider Gains Off Limits: Judge
- Drugmaker Agrees To Reviews Over Fake Data Claims
- PharmAthene Wins Share Of SIGA Smallpox Drug Profits
- Medicis Settles Investors' Fraud Action For $18M
- Cephalon Challenges Sun's Anti-Epilepsy Generic
- 6th Circ. Affirms Toss Of Generic Drug Labeling Suits
- UPS, FedEx Settle Network Signatures IP Suits
- Greenberg Traurig Snags King & Spalding Patent Vet
- Bayer Unit Can't Stop Rival Acne Drug Statements: Judge
- Medtronic Must Produce InFuse Docs In Securities Suit
- FDA Yanks Ozone-Depleting Inhaler From Market
- J&J Washes Hands Of Baby Bath Products False Ad Suit
- Judge Bars Mylan's Generic Doryx For Now
- Roche, Mylan Settle Suit Over Generic Cancer Drug
- South Korea Fines Drug Cos. $9.6M Over Kickbacks
- Head Of France's Servier Probed Over Diabetes Drug
- White & Case Nabs Norton M&A Vet For Abu Dhabi Office
- Express Scripts Can't Shake Suit Over $29B Merger
- J&J Loses Bid For New Trial In $482M Stent Patent Case
- The 5 'PRs' Of Product Preservation
- Jury Hands Medtronic $101M In Spine Device IP Fight
- Sandoz Settles Texas Drug Inflation Claims For $66M
- Express Scripts, Medco Say Deal Will Boost Competition
- Excelsior Spread Lies About Rival's IV Cap, Suit Says
- How They Won It: Kaye Scholer Saves Pfizer's Viagra Patent
- Teva Must Pay Baxter's $144M Hepatitis Damages: Judge
- Cordis Loses Challenge Over USPTO Evidence Rules
- Dendreon Overstated Demand For Provenge: Investors
- Orix Unit Boosts Health PE Firm With $150M Infusion
- Boston Scientific Dodges Fraud Suit Over Firings
- Adidas Says Herbalife Breached Tri-Leaf Logo Deal
- FTC Investigates Valeant's Dermatology Buys
- Innovative Procedures V. Premarketing Approval
- Beckman Reaches $5.5M Settlement In Shareholder Suit
- FDA Chemist, US Close To Deal In Insider Trading Case
- Kramer Levin Opens Silicon Valley IP Office
- Genentech Says Prior Suit Bars HGS' Antitrust Claims
- Sun Pharma NJ Plant Passes FDA Review After Warning
- GSK OTC Products Spark Bidding War
- Court Joins 3 Google Investor Suits Over Illegal Drug Ads
- Sun Can't Sell Generic Eloxatin Until 2012: Judge
- Fresenius Sues InvaGen Over Generic PhosLo GelCaps
- Watson Exits Medicaid Drug Inflation MDL For $79M
- Ceragenix Whistleblower Takes $10M Suit To Colorado
- Metal Hip Implants Fail Faster Over Time: UK Report
- GSK's Zofran Could Lead To Abnormal Heart Rhythms: FDA
- Qualitest Recalls Mispackaged Birth Controll Pills
- Applied, Covidien Head To Trial Over Surgical Tool IP
- Cephalon Sues Sandoz Again Over Generic Fentora
- Ortho-McNeil Defends Foreign Patent Ruling In 7th Circ.
- Obama Signs Patent Reform Into Law
- Health Exam: Muni Health Care Bankruptcy Under Ch. 9
- Fenwal Didn't Infringe Blood Centrifuge Patent: Judge
- 2 Men Charged With Trading On Drug Co. Merger Tips
- Aurobindo Settles Medicis Patent Suit Over Solodyn
- Conflicting Post-Bilski Cases: Classen And CyberSource
- SC Johnson Sues Nutraceutical Over 'Bug Off' Mark
- Astellas Accused Of Delaying Generic Drug Approval
- J&J Units, Kremers Urban End Concerta Patent Suit
- J&J Unit To Shell Out $85M Over Bad Natrecor Labeling
- Case Study: Pernod V. Bacardi
- SEC Taps Fenwick Ace For Small Biz Investment Panel
- Takeda Hits Accord With Suit Over Actos ANDA
- Judge Greenlights Deal In Baby Sex Test Row
- Case Study: Interpharm V. Wells Fargo
- House Panel To Review Express Scripts' $29B Medco Buy
- FDA Warns Luitpold Over Drug Manufacturing Violations
- Mitsui Dodges Duke Hospital Contamination Suit Coverage
- Stock Promoter Gets 16 Months For Broker Bribery
- Nixon Peabody Expands Boston Team With Foley IP Attys
- Judge Clears HHS Financial Test For Equipment Suppliers
- Myriad — Fueling The Debate Over DNA Patents
- Sequenom Patent Agent Gets Probation For Insider Trading
- J&J Supplier's Bug Infestation Suit Survives Dismissal Bid
- PharMerica Sued Over Rebuffed $441M Omnicare Deal
- Caliper Investor Sues To Block $600M PerkinElmer Deal
- FTC Urges Pay-For-Delay Limits To Ease Deficit Woes
- Compound Animal Drugs Not Under FDA Authority: Court
- General Dynamics Settles DataTern Patent Suit
- US Pushes Drug Access Plan At Trans-Pacific Talks
- Ex-Howrey Chief Joins Winston & Strawn's Litigation Team
- Novelos Claims Securities Action Strikes Out
- Double Duty: Plaintiff's Doctor As Expert Witness
- GSK Sues Mylan, Impax Over Generic Prostate Drugs
- Flamel Seeks To Block Generic Coreg
- EU Trade Group Backs FDA's $300M Generics Fees Plan
- Dems Urge FTC To Dig Into Express Scripts-Medco Deal
- FDA Seeks Clearer Rules For Use Of Osteoporosis Meds
- Patent Reform Bill Clears Senate, Heads To Obama
- Genzyme Not Liable In Carticel Negligence Suit: 11th Circ.
- Hospital Bigwigs Off Hook In Medicare Fraud Suit
- Cadwalader M&A Heavyweight Jumps To Greenberg
- WilmerHale Reps PerkinElmer In $600M Caliper Buy
- AvMed Exits Class Suit Alleging Provigil Conspiracy
- Teva, Sandoz Infringed Allergan's Lumigan Patents: Judge
- Pfizer Didn't Breach Antitrust Laws: Indonesian Court
- Navy Holds On To Win Over $15M Drug Testing Contract
- The Skinny On Skinny Labels
- Express Scripts Sues Walgreen Over Disparagement
- Teva's Copaxone Trial Kicks Off Against Mylan, Sandoz
- Omnicare Takes $716M Bid For PharMerica Hostile
- Chinese Cos. Can't Shake Vitamin C Antitrust MDL
- Mylan, Cephalon Spar In Fed. Circ. Over Amrix MDL Ruling
- Case Study: SPX V. Master Cool
- Acorda Loses Patent Fight Over Apotex's Generic Zanaflex
- Shareholders Accuse Bovie Board Of Mismanagement
- Par, Others Targeted In Medicaid Fraud Suit
- $8M Settlement Reached In ArthroCare Shareholder Suit
- Abbott Can't Duck $3.5M Norvir Verdict For GSK: Judge
- Former Duane Reade CFO Skirts Prison Term
- FDA Questions Safety Of J&J, Bayer's Xarelto
- Ex-FDA Counsel Returns To Morgan Lewis
- Former Acting SG Katyal Heads To Hogan Lovells
- Amid Scandals, J&J CEO's Pay Was Too High: Suit
- The Myriad Appeal: DNA Patent-Eligibility Under § 101
- WebMD Faces Class Action Over Faulty Financials
- CardioNet Can't Escape IPO Class Action
- FDA Unveils New Fee Proposal For Drug Reviews
- FTC Eyes Evolving Pay-For-Delay Drug Deals
- Canadian Court Won't Let GSK Access Paxil Medical Docs
- Shook Hardy Nabs Fish & Richardson Health IP Pro
- Jury To Rule On Standing In UPenn Alzheimer's IP Row
- WebMD Shareholders Sue Board Over Rosy Forecasts